openPR Logo
Press release

Frost & Sullivan Co-published the 2025 Global Bio-fermented Type III Collagen Market Research Report with Jland Biotech

05-13-2025 06:30 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Getnews

/ PR Agency: SHENZHEN HMEDIUM INFORMATION TECHNOLOGY CO.,LTD
Frost & Sullivan Co-published the 2025 Global Bio-fermented

Frost & Sullivan and Jland Biotech have conducted comprehensive research on the global collagen industry and co-published the "2025 Global Bio-fermented Type III Collagen Market Research Report" on March 13, 2025. The report aims to analyze the latest technological innovations, application scenarios, and market dynamics for bio-fermented type III collagen. It explores the bio-fermentation process, biological functionality, and regulatory landscape of this emerging collagen type, highlighting its expanding role across aesthetic medicine, wound healing, functional skincare, and other high-value fields. The report seeks to provide in-depth insights for industry participants and investors, encouraging forward-looking discussions on the future trajectory of bio-fermented type III collagen. (To read the 2025 Global Bio-fermented Type III Collagen Market Research Report , visit: https://hub.frost.com/a-next-generation-biomaterial-with-expanding-commercial-applications/)

Collagen is the most abundant structural protein in the human body, essential for maintaining the strength and elasticity of skin, connective tissue, and organs. Among its many types, Type III collagen has drawn growing attention for its critical role in skin regeneration, vascular architecture, and tissue elasticity.

Predominantly found in the skin, blood vessels, and internal organs, Type III collagen forms fine reticular fibers within the extracellular matrix (ECM), supporting the structural framework of soft tissues. Working synergistically with Type I collagen, it ensures mechanical resilience in high-compliance organs such as blood vessels and the intestinal wall, and is essential for preserving normal tissue morphology and function.

Bio-fermented type III collagen plays a key role in tissue regeneration by promoting fibroblast proliferation, enhancing cell adhesion, and stimulating the production of structural proteins essential for skin repair. It contributes to extracellular matrix remodeling and helps rebuild damaged tissue, making it highly effective in wound healing and post-procedural recovery. Additionally, it reduces oxidative stress and glycation, two major factors in skin aging, thereby supporting long-term dermal health. Its regenerative response is dynamically regulated, upregulated during damage repair, and stabilized as homeostasis is restored, which underpins its value in both therapeutic and cosmetic applications.

Bio-fermented type III collagen combines high structural precision, bioactivity, and safety, free from animal-derived contaminants, making it suitable for diverse functional applications. It enhances fibroblast proliferation, elastic fiber synthesis, and barrier repair, with efficacy verified through in vitro and ex vivo studies. These regenerative properties support its growing use in medical aesthetics, wound dressings, and advanced skincare formulations. Beyond cosmetic and medical use, its structural integrity, low immunogenicity, and absorption efficiency also enable applications across broader sectors. Developed through precision fermentation and bio-engineering, this next-generation collagen mimics native human collagen in both sequence and function. It is now being incorporated into functional foods, and nutritional supplements, as well as more specialized areas such as oral and nasal care, scalp health, and intimate care. Its versatility further extends to tissue engineering as bio-scaffolds and injectable fillers for non-invasive reshaping, demonstrating broad potential across both consumer health and clinical innovation.

With breakthroughs in technology and rising consumer demand, the bio-fermented type III collagen market has experienced explosive growth in recent years and is expected to maintain rapid expansion. According to data from Frost & Sullivan, from 2020 to 2023, the global bio-fermented type III collagen raw material market grew from USD 17.9 million to USD 146.5 million, with a compound annual growth rate (CAGR) of 101.6%. By 2030, this figure is projected to reach USD 1.586 billion, accounting for 41.6% of the global collagen raw material market. In the functional skincare sector, the penetration of bio-fermented type III collagen has also increased sharply-in China, its share in collagen-based skincare raw materials is 57.8% in 2023, and is expected to approach 89.3% by 2030. This momentum is not only driving aesthetic medicine toward greater precision and safety but also offering new solutions for chronic wound healing and skin barrier restoration. In short, bio-fermented type III collagen is translating scientific breakthroughs into tangible health value: it is reshaping the fields of medicine, aesthetics, and regenerative therapies, and injecting strong momentum into the sustained growth of the global beauty and wellness industries.

Jland Biotech has 20 years of in-depth technical expertise in the field of functional Bio-fermented proteins, particularly in bio-engineering and green bioprocess. This technology enables the efficient and eco-friendly production of multiple types of Bio-fermented collagen, eliminating the limitations of traditional collagen production methods. It facilitates product differentiation while maintaining strong market competitiveness.

Jland Biotech has developed Bio-fermented collagen raw materials for applications in cosmetics, medical devices, and food. Building on raw material development, Jland is actively expanding the applications of Bio-fermented collagen. Currently, Jland has established a full industrial chain service system for Bio-fermented collagen, covering gene design, pilot scale-up, Ton-scale industrial production, and downstream application and development. The company is committed to advancing Bio-fermented collagen raw materials toward higher quality and greater cost-effectiveness in the future.

The 2025 Global Bio-fermented Type III Collagen Market Research Report highlights the following:

- Chapter 1: Introduction and Market Size (definition, structure, classification, function, market)

- Chapter 2: Application in Functional Skincare (market analysis, regulations, global market, efficacy and safety)

- Chapter 3: Application in Aesthetic Medicine (market analysis, regulations, global market, efficacy and safety)

- Chapter 4: Application in Medical Devices (market, regulations, 3D bio-printing, global market)

- Chapter 5: Applications in the Food Industry (market analysis, regulations, global market, efficacy and safety)

- Chapter 6: Application in Scalp Care (market analysis, regulations, global market, efficacy and safety)

- Chapter 7: Application in Intimate Care (market analysis, global market)

- Chapter 8: Applications in Other Fields (personal care products, oral care products, nasal care products)

- Chapter 9: Industry Drivers and Development Trends (industry driver, future development)

- Chapter 10: Company Case Study - Jland Biotech

Key Topics Covered:

1. An Overview of Type III Collagen and Its Market Size

a. Understanding of Collagen

b. Understanding bio-fermented Type III Collagen

c. Bio-fermented Type III Collagen Market Size

2. Application of bio-fermented Type III Collagen in Functional Skincare

a. Market Analysis of bio-fermented Type III Collagen in Functional

b. Regulatory Analysis of bio-fermented Type III Collagen in Functional Skincare

c. Global Market Analysis of bio-fermented Type III Collagen/bio-fermented Collagen

d. Efficacy and Safety of bio-fermented Type III (JYC301) in Skincare Products

3. Application of bio-fermented Type III Collagen in Aesthetic Medicine

a. Market Analysis of bio-fermented Type III Collagen Aesthetic Medical Products

b. Regulatory Analysis of bio-fermented Type III Collagen Aesthetic Medicine Products

c. Global Market Analysis of bio-fermented Type III Collagen/bio-fermented Collagen

d. Efficacy and Safety Analysis of bio-fermented Type III (JYC301) in Aesthetic Product

4. Application of bio-fermented Type III Collagen in Other Medical Device Fields

a. Market Analysis of bio-fermented Type III Collagen Medical Devices

b. Regulatory Analysis of bio-fermented Type III Collagen Medical Device Applications of bio-fermented Type III Collagen - Aesthetic Medicine

c. Bio-fermented Type III Collagen 3D Bioprinting Medical Devices

d. Global Market Analysis of bio-fermented Type III Collagen / bio-fermented Collagen Medical Devices

5. Applications of bio-fermented Type III Collagen in the Food Industry

a. Market Analysis of bio-fermented Type III Collagen in the Food Industry

b. Regulatory Analysis of bio-fermented Type III Collagen Food

c. Analysis of Globally Marketed bio-fermented Type III Collagen/Collagen Foods

d. Bio-fermented Type III Collagen (JYC301) Food Ingredient Efficacy and Safety Analysis

6. Application of bio-fermented Type III Collagen in Scaple Care

a. Market Analysis of bio-fermented Type III Collagen in Scalp Care

b. Regulatory Analysis of bio-fermented Type III Collagen in Scalp Care

c. Analysis of Globally Marketed bio-fermented Type III Collagen/bio-fermented Collagen Scalp Care Products

d. Bio-fermented Type III Collagen (JYC301) Scalp Care Products Efficacy and Safety Analysis

7. Application of bio-fermented Type III Collagen in the Intimate Care Field

a. Market Analysis of bio-fermented Type III Collagen in Intimate Care

b. Global Market Analysis of bio-fermented Type III Collagen/Collagen Intimate Care

c. Bio-fermented Type III Collagen (JYC301) Private Care Products: Efficacy and Safety Analysis

8. Applications of bio-fermented Type III Collagen in Other Fields

a. Analysis of bio-fermented Type III Collagen Personal Care Products

b. Analysis of bio-fermented Type III Collagen Oral Care Products

c. Analysis of bio-fermented Type III Collagen Nasal Care Products

9. Industry Drivers and Future Development Trends of bio-fermented Type III Collagen

a. Industry Drivers of bio-fermented Type III Collagen

b. Future Development Trends of bio-fermented Type III Collagen

10. Outstanding Company Case of bio-fermented Collagen: Jland Biotech

Image: https://www.globalnewslines.com/uploads/2025/05/a97d8633610c5a528c601a95c8f93697.jpg

Source: Frost & Sullivan Analysis

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 60 years, Frost & Sullivan has been developing growth strategies for the global 1000, emerging businesses, the public sector, and the investment community.

About Jland Biotech

Jland Biotech is a high-tech enterprise specializing in the industrial design and application of bioengineered Bio-fermented proteins. Since its establishment in 2015, the company has set up 3 marketing centers, 4 production bases, and 5 R&D centers globally.

Jland Biotech has built a comprehensive industrial chain platform for Bio-fermented proteins, covering gene design, strain construction, industrial design, ton-scale production capacity expansion, downstream application research, and safety and efficacy testing of downstream products. Leveraging cutting-edge technologies in gene recombination, microbial fermentation, and protein separation and purification, the company has achieved large-scale production of multiple functional proteins.

As one of the world's largest manufacturers of Bio-fermented collagen, Jland Biotech leads the world in the unit expression of Bio-fermented collagen.

As a full industrial chain platform integrating R&D, production, and sales of Bio-fermented collagen, Jland Biotech has established a comprehensive product system covering raw materials, medical products, functional skincare products, and functional foods. The company's products serve global manufacturing enterprises, medical institutions, and end users in diverse fields such as pharmaceuticals, medical aesthetics, cosmetics, biomimetic materials, and food and health supplements, serving over 40 countries and regions, including those in Europe, America, and Asia.
Media Contact
Company Name: Frost & Sullivan
Contact Person: Qian Li
Email: Send Email [http://www.universalpressrelease.com/?pr=frost-sullivan-copublished-the-2025-global-biofermented-type-iii-collagen-market-research-report-with-jland-biotech]
Country: China
Website: http://www.frostchina.com

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. GetNews makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Frost & Sullivan Co-published the 2025 Global Bio-fermented Type III Collagen Market Research Report with Jland Biotech here

News-ID: 4014042 • Views:

More Releases from Getnews

Inspire Ambitions Unveils New Report Showing Graduate Expectation Gap in the UAE Workforce
Inspire Ambitions Unveils New Report Showing Graduate Expectation Gap in the UAE …
Inspire Ambitions launches "The 2025 Graduate Expectation Gap Report," highlighting disconnects between student career expectations and workplace realities. Image: https://www.globalnewslines.com/uploads/2025/09/6f6df43eab6fb7f22996fcc669a39629.jpg A new report released today by Inspire Ambitions [https://inspireambitions.com/], The 2025 Graduate Expectation Gap Report [https://inspireambitions.com/product/from-campus-to-career/], reveals that a significant majority of recent graduates in the UAE feel unprepared for the realities of today's workplace. The findings shed light on a widening divide between university preparation and the skills needed to succeed
Future Electronics and Infineon to Host Free Webinar on Next-Generation Smart HMI Design with PSOC Trademark Edge
Future Electronics and Infineon to Host Free Webinar on Next-Generation Smart HM …
Image: https://www.globalnewslines.com/uploads/2025/09/1757697276.jpg Future Electronics & Infineon's free webinar on Sept 25 to explore how PSOC Trademark Edge powers next-gen smart HMIs with AI, voice & gesture control. Montreal, Canada - September 12, 2025 - Future Electronics, a leading global distributor of electronic components, is pleased to announce an upcoming free webinar hosted in collaboration with Infineon Technologies: Unlock Innovation with PSOC Trademark Edge for Next-Gen Smart HMIs. The live session will take place
RoadMap Advisors Enhances Sell-Side M&A Services for Middle Market Business Owners
RoadMap Advisors Enhances Sell-Side M&A Services for Middle Market Business Owne …
Image: https://www.globalnewslines.com/uploads/2025/09/1757662626.jpg RoadMap Advisors, a Virginia-based consulting firm, has refined its sell-side M&A service offerings to provide greater process efficiency, buyer alignment, and transaction readiness for business owners seeking full or partial exits. Vienna, VA - September 12, 2025 - RoadMap Advisors, a leading consulting firm in Tysons, VA [https://www.roadmapadvisors.com/], has announced the refinement of its sell-side mergers and acquisitions (M&A) services [https://www.roadmapadvisors.com/mergers-acquisitions/sell-side/], incorporating a structured, advisor-led process designed to help business
MFE Insurance Responds to Industry Shift as Studios Turn to DICE Insurance for Innovative Productions
MFE Insurance Responds to Industry Shift as Studios Turn to DICE Insurance for I …
Image: https://www.globalnewslines.com/uploads/2025/09/1757659532.jpg MFE Insurance is offering custom DICE insurance policies for studios and filmmakers seeking to innovate their productions. Los Angeles, CA - September 12, 2025 - As audience expectations continue to shift and demand for high-impact, visually memorable content rises, producers and production companies are pushing creative boundaries like never before. MFE Insurance, a national leader in entertainment, cannabis, and event insurance, [https://www.mfeinsurance.com/] is meeting that evolution head-on with customized DICE

All 5 Releases


More Releases for III

Ytterbium(III) Sulfate Market Size and Forecast
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global Ytterbium(III) Sulfate Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion. Ytterbium(III) Sulfate Market Size And Scope The Ytterbium(III) Sulfate market is projected to grow significantly, with a market size valued at approximately USD 110.3 million in
Iron(III) Isopropoxide Market 2024 Research Report
Iron(III) Isopropoxide Market The global Iron(III) Isopropoxide market was valued at US$ 62 million in 2023 and is anticipated to reach US$ 99 million by 2030, witnessing a CAGR of 7.0% during the forecast period 2024-2030. View Sample Report https://reports.valuates.com/request/sample/QYRE-Auto-10Y12819/Global_Iron_III_Isopropoxide_Industry_Research_Report_Growth_Trends_and_Competitive_Analysis_2022_2028 Report Scope The Iron(III) Isopropoxide market size, estimations, and forecasts are provided in terms of output/shipments (Gram) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the
What is Ruthenium III Chloride used for?
Ruthenium(III) chloride hydrate, also known as ruthenium trichloride hydrate, is a compound of great significance in various fields. This compound consists of ruthenium, chlorine and water molecules. With its unique properties, ruthenium(III) chloride hydrate has a wide range of applications in different industries. In this article, we explore the uses of ruthenium(III) chloride and emphasize its importance. Ruthenium(III) chloride hydrate is widely used as a catalyst in organic synthesis. It can
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) Therapeutics - Pipelin …
Mucopolysaccharidosis type III (MPS III), also known as Sanfilippo syndrome, is a progressive disorder that primarily affects brain and spinal cord (central nervous system). People with MPS III generally do not display features at birth, but they begin to show signs and symptoms of this disorder during early childhood. Affected children often initially have delayed speech and behaviour problems. Download the sample report @ https://www.pharmaproff.com/request-sample/1146 In later stages of this disorder, people
Global Antithrombin III Deficiency Testing Market
The Antithrombin III Deficiency Testing Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. Antithrombin deficiencies are mainly divided into two types: type I and type II. The type I antithrombin deficiency is characterized by an inadequate amount of normal antithrombin present in
EXCEEMO Industrial SATA III SSD
Extremely impressive performance, the highest reliability and guaranteed fixed BOM - all in one service package for industrial customers EXCEEMO, the memory and storage specialist from Landsberg am Lech, presents the industrial 2.5“ SATA III Solid-State-Drives with ultra-fast read/write transfer speed of up to 555MB/515MB per second and proven long-term reliability. The noiseless, energy-efficient and particularly robust solid state drives are available both in standard grade (0°/+70°C-MLC/SLC) and in industrial